Neurology : Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome is organized by American Academy of Neurology (AAN) and will be held during Aug 29, 2017 - Aug 29, 2020.
Conference Objectives are :
Upon completion of the article by Hennes et al, the participant should be able to:
• Identify clinical features in this study seen in conjunction with high anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a cohort of children with acquired demyelinating syndromes
• Describe the prognostic role for anti-MOG antibodies in identifying children after an initial demyelinating event who are at high risk of subsequent development of multiple sclerosis (MS) in this study
• Discuss the sensitivity and specificity of anti-MOG antibodies in the diagnosis of non-MS disease courses following an initial demyelinating event observed in this study
Additional details will be posted as soon as they are available.